Bronchosolvin Syrup
Guaifenesin + Terbutaline + Bromhexine
60ml
Ipca Laboratories Ltd.
| Pack size | 1 |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 43.96 NPR |
Indications
Bronchosolvin Syrup is used for:
Productive cough associated with bronchitis, bronchial asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, and emphysema.
Adult Dose
Oral
Adult: 1-2 tsf 3 times daily
Child Dose
Renal Dose
Administration
Contra Indications
Hypersensitivity to any of the component in the preparation. Children below 3 years of age.
Precautions
Cautious use is recommended in patients with hepatic impairment, renal impairment, chronic lung disease, cardiac failure, hypertension, high fever, hyperthyroidism, arrhythmias, pulmonary edema, diabetes mellitus, convulsive disorders, history of peptic ulcers and in breast feeding & pregnant women.
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Guaifenesin + Terbutaline + Bromhexine :
The common adverse events are angina, tremor, headache, anorexia, muscle cramps, palpitations, nausea, irritability, insomnia, heartburn, gastritis, anxiety, nervousness, central nervous disturbances. Behavioral disturbances may occur in children.
Mechanism of Action
Terbutaline is a direct-acting sympathomimetic which relaxes bronchial smooth muscle by selective action on beta2 receptors. It also decreases uterine contractility.
Bromhexine is a mucolytic.
Guaifenesin increases the volume and reduce the viscosity of tenacious sputum and is used as an expectorant for productive cough.
Note
Bronchosolvin 60ml Syrup manufactured by Ipca Laboratories Ltd.. Its generic name is Guaifenesin + Terbutaline + Bromhexine. Bronchosolvin is availble in Nepal.
Farmaco Nepal drug index information on Bronchosolvin Syrup is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.